A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression
IntroductionAs one of the most frequently diagnosed mental disorders, depression is expected to become the most common disease worldwide by 2030. Previous studies have shown that Chaihu Anxin Capsule has powerful antidepressant effects. However, its mechanisms are not fully understood. The aim of ou...
Main Authors: | Lin Yang, Yan Zhao, Ruochen Qu, Yan Fu, Chunhua Zhou, Jing Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1256045/full |
Similar Items
-
A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
by: Zu Gao, et al.
Published: (2022-12-01) -
The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis
by: Yang Zhao, et al.
Published: (2023-09-01) -
Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction
by: Qiao-feng Li, et al.
Published: (2022-04-01) -
Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
by: Xiaofei Zhu, et al.
Published: (2022-01-01) -
Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
by: Zhang S, et al.
Published: (2021-08-01)